Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 5Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3Head and Neck Neoplasms 3Pain 2Lung Neoplasms 2Colorectal Neoplasms 2Cancer Pain 2Wounds and Injuries 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Recurrent Laryngeal Nerve Injuries 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Pilonidal Sinus 1Pain, Postoperative 1Pain, Intractable 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Liver Neoplasms 1Intracranial Aneurysm 1Ileus 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Disease Progression 1Constipation 1Colonic Neoplasms 1Breast Neoplasms 1Agnosia 1Accessory Nerve Injuries 1

Interventions

Docetaxel 21Radiosurgery 20Radiotherapy 17Androgen Antagonists 14Leuprolide 12Goserelin 12bicalutamide 11Prednisone 9Gonadotropin-Releasing Hormone 9Abiraterone Acetate 9enzalutamide 8Surveys and Questionnaires 8Radiotherapy, Intensity-Modulated 8Brachytherapy 8Blood Specimen Collection 8acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7Triptorelin Pamoate 7Multiparametric Magnetic Resonance Imaging 7abiraterone 5pembrolizumab 4cabazitaxel 4Standard of Care 4Positron Emission Tomography Computed Tomography 4Metformin 4Heavy Ion Radiotherapy 4Flutamide 4Exercise 4Estramustine 4luprolide acetate gel depot 3darolutamide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms × Lidocaine × Clear all
NCT05957653 2023-07-24

Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort

RenJi Hospital

Phase 4 Unknown
140 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡